Barings’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-739
Closed -$260K 175
2023
Q2
$260K Hold
739
0.01% 153
2023
Q1
$233K Buy
+739
New +$222K 0.01% 151
2022
Q3
Sell
-1,723
Closed -$486K 322
2022
Q2
$486K Buy
+1,723
New +$461K 0.02% 204
2022
Q1
Sell
-1,135
Closed -$249K 390
2021
Q4
$249K Buy
+1,135
New +$221K 0.01% 351
2021
Q3
Sell
-5,671
Closed -$1.14M 440
2021
Q2
$1.14M Sell
5,671
-126
-2% -$26.4K 0.03% 202
2021
Q1
$1.25M Sell
5,797
-482
-8% -$106K 0.03% 208
2020
Q4
$1.48M Sell
6,279
-15,561
-71% -$3.57M 0.04% 191
2020
Q3
$5.94M Buy
21,840
+7,804
+56% +$2.15M 0.14% 125
2020
Q2
$3.34M Hold
14,036
0.11% 152
2020
Q1
$3.34M Sell
14,036
-412
-3% -$94.5K 0.11% 152
2019
Q4
$3.16M Sell
14,448
-7,171
-33% -$1.45M 0.08% 186
2019
Q3
$3.66M Sell
21,619
-752
-3% -$133K 0.08% 185
2019
Q2
$4.1M Buy
22,371
+6,842
+44% +$1.2M 0.09% 185
2019
Q1
$2.86M Buy
15,529
+7,952
+105% +$1.47M 0.07% 216
2018
Q4
$1.26M Buy
7,577
+1,715
+29% +$297K 0.02% 340
2018
Q3
$1.13M Hold
5,862
0.02% 465
2018
Q2
$996K Buy
5,862
+3,202
+120% +$496K 0.01% 510
2018
Q1
$434K Hold
2,660
0.01% 734
2017
Q4
$399K Buy
+2,660
New +$394K 0.01% 775
2016
Q1
Sell
-2,300
Closed -$289K 982
2015
Q4
$289K Hold
2,300
0.01% 780
2015
Q3
$240K Hold
2,300
0.01% 804
2015
Q2
$284K Hold
2,300
0.01% 831
2015
Q1
$271K Hold
2,300
0.01% 840
2014
Q4
$273K Hold
2,300
0.01% 811
2014
Q3
$258K Hold
2,300
0.01% 842
2014
Q2
$218K Buy
+2,300
New +$161K 0.01% 913

Other funds holding VRTX